Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trial

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2024-10-24
DOI
https://doi.org/10.1016/j.eclinm.2024.102879
Citations
3
Primary Topic
Phagocytosis and Immune Regulation
Type
article
Field-Weighted Citation Impact
0.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trial

Martin Kappler, Andriy Krendyukov, Julián Pardo, Felix Herth et al.
3 citations
EClinicalMedicine
Phagocytosis and Immune Regulation
0.72
article

Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trial

Martin Kappler, Andriy Krendyukov, Julián Pardo, Felix Herth, Harald Fricke, Christiane Dings, Michael Bergmann, Christian Schoergenhofer, Christine Straub, Thorsten Lehr, Bernd Jilma, Henning Walczak, Diego de Miguel, Meinolf Thiemann, M Seco, José Ramón Paño Pardo, Thomas Hoeger
article en
3 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 77
University of Cologne (DE), Universidad de Zaragoza (ES), Instituto de Salud Carlos III (ES), Apogenix (Germany) (DE), Comprehensive Cancer Center Vienna (AT), Hautklinik Heidelberg (DE), Frauenklinik Heidelberg (DE), Hospital Clínico Universitario Lozano Blesa (ES), Instituto de Investigación Sanitaria Aragón (ES), CRUK Lung Cancer Centre of Excellence (GB), Hospital Universitario Infanta Sofía (ES), Instituto de Investigación de Enfermedades Raras (ES), University College London (GB), Medical University of Vienna (AT), Saarland University (DE), Cytel (United States) (US)
Alexander von Humboldt-Stiftung, Wellcome Trust, Ministerio de Ciencia, Innovación y Universidades, Deutsche Forschungsgemeinschaft, Vienna Science and Technology Fund, Fundación Agencia Aragonesa para la Investigación y el Desarrollo, Medical Research Council
Good health and well-being
Openalex Percentile: Top 28%
Phagocytosis and Immune Regulation
0.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.